Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Viatris ( (VTRS) ) is now available.
On February 3, 2026, Viatris Inc. reported that Chief Legal Officer Brian Roman will step down from his role effective February 9, 2026, and remain with the company until April 1, 2026, to facilitate a transition, during which he will receive separation benefits in line with those granted to comparable executives. The company also announced that veteran pharmaceutical industry lawyer Matthew Maletta, formerly Executive Vice President, Chief Legal Officer and Secretary of Endo, Inc. from 2015 to 2025, will assume the Chief Legal Officer position on February 9, 2026, marking a planned leadership handover in Viatris’ legal function that underscores continuity and sector-specific experience at the top of its legal organization.
The most recent analyst rating on (VTRS) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Viatris stock, see the VTRS Stock Forecast page.
Spark’s Take on VTRS Stock
According to Spark, TipRanks’ AI Analyst, VTRS is a Neutral.
Viatris’ overall stock score is driven by its strategic initiatives and positive technical momentum. However, financial challenges, particularly in profitability and valuation, weigh on the score. The company’s proactive steps in addressing operational issues and enhancing its market position are positive, but the financial performance remains a critical area for improvement.
To see Spark’s full report on VTRS stock, click here.
More about Viatris
Average Trading Volume: 8,762,979
Technical Sentiment Signal: Buy
Current Market Cap: $15.08B
For detailed information about VTRS stock, go to TipRanks’ Stock Analysis page.